Bailard Inc. Invests $322,000 in AdaptHealth Corp. (NASDAQ:AHCO)

Bailard Inc. acquired a new stake in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 29,700 shares of the company's stock, valued at approximately $322,000.

Other large investors also recently added to or reduced their stakes in the company. SummerHaven Investment Management LLC raised its stake in AdaptHealth by 1.7% in the 1st quarter. SummerHaven Investment Management LLC now owns 79,883 shares of the company's stock valued at $866,000 after purchasing an additional 1,329 shares during the last quarter. Guggenheim Capital LLC raised its position in shares of AdaptHealth by 10.1% in the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock valued at $158,000 after buying an additional 1,525 shares during the last quarter. Sterling Capital Management LLC raised its position in shares of AdaptHealth by 5.2% in the fourth quarter. Sterling Capital Management LLC now owns 33,558 shares of the company's stock valued at $319,000 after buying an additional 1,644 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of AdaptHealth by 3.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 57,931 shares of the company's stock worth $552,000 after buying an additional 1,999 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its position in AdaptHealth by 6.8% during the first quarter. Oppenheimer Asset Management Inc. now owns 32,797 shares of the company's stock worth $356,000 after acquiring an additional 2,081 shares during the last quarter. 82.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

AHCO has been the subject of a number of recent research reports. Truist Financial cut their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. Royal Bank Of Canada cut their price target on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a report on Thursday, May 8th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, AdaptHealth presently has an average rating of "Buy" and a consensus price target of $13.40.

AdaptHealth Trading Down 4.4%

AdaptHealth stock traded down $0.42 during midday trading on Thursday, hitting $9.22. 1,332,033 shares of the stock were exchanged, compared to its average volume of 1,361,685. The company has a current ratio of 1.29, a quick ratio of 1.07 and a debt-to-equity ratio of 1.25. The stock has a market capitalization of $1.24 billion, a price-to-earnings ratio of 16.18, a PEG ratio of 0.93 and a beta of 1.63. The stock's 50-day simple moving average is $9.02 and its 200 day simple moving average is $9.39. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.90.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.